Evidence map›Paper›PMID 27280444›Full record

ArticlePloS one2016

HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis.

Erica Silberstein, Laura Ulitzky, Livia Alves Lima, Nicoleta Cehan, Andréa Teixeira-Carvalho, Philippe Roingeard, Deborah R Taylor

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Erica SilbersteinLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Laura UlitzkyLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Livia Alves LimaLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Nicoleta CehanLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Andréa Teixeira-CarvalhoLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Philippe RoingeardINSERM U966, Universite Francois Rabelais and CHRU de Tours, Tours, France.
Deborah R TaylorLaboratory of Emerging Pathogens, Division of Emerging Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER FDA, Silver Spring, MD, 20903, United States of America.
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Hepatitis C Virus (HCV) infection is associated with progressive liver injury and subsequent development of fibrosis and cirrhosis. The death of hepatocytes results in the release of cytokines that induce inflammatory and fibrotic responses. The mechanism of liver damage is still under investigation but both apoptosis and immune-mediated processes may play roles. By observing the changes in gene expression patterns in HCV-infected cells, both markers and the causes of HCV-associated liver injury may be elucidated. HCV genotype 1b virus from persistently infected VeroE6 cells induced a strong cytopathic effect when used to infect Huh7.5 hepatoma cells. To determine if this cytopathic effect was a result of apoptosis, ultrastructural changes were observed by electron microscopy and markers of programmed cell death were surveyed. Screening of a human PCR array demonstrated a gene expression profile that contained upregulated markers of apoptosis, including tumor necrosis factor, caspases and caspase activators, Fas, Bcl2-interacting killer (BIK) and tumor suppressor protein, p53, as a result of HCV genotype 1b infection. The genes identified in this study should provide new insights into understanding viral pathogenesis in liver cells and may possibly help to identify novel antiviral and antifibrotic targets.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCarcinoma, HepatocellularHepacivirusHepatitis CHepatocytesHumansLiver NeoplasmsTumor Cells, CulturedApoptosis Regulatory Proteins

Identifiers

PMID27280444
PMCPMC4900611
OpenAlexW2418609093

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.